In 2026, deep vein thrombosis accounts for 39.6% of the vascular thromboembolic disease thrombectomy market by disease type. The largest device type share, 41.3%, belongs to aspiration thrombectomy devices; the procedure category is led by endovascular thrombectomy with 31.5%.